These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17068007)

  • 21. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
    Grandgirard D; Schürch C; Cottagnoud P; Leib SL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of delayed cerebrospinal fluid sterilization of pneumococcal meningitis in children].
    Hées L; Gillet Y; Levy C; Varon E; Bingen E; Cohen R; Floret D;
    Arch Pediatr; 2008 Dec; 15 Suppl 3():S119-25. PubMed ID: 19268241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
    Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis.
    Barichello T; Ceretta RA; Generoso JS; Moreira AP; Simões LR; Comim CM; Quevedo J; Vilela MC; Zuardi AW; Crippa JA; Teixeira AL
    Eur J Pharmacol; 2012 Dec; 697(1-3):158-64. PubMed ID: 23085269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains.
    Faella F; Pagliano P; Fusco U; Attanasio V; Conte M
    Clin Microbiol Infect; 2006 Apr; 12(4):391-4. PubMed ID: 16524418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The activity of antibiotics in combination versus Streptococcus pneumoniae. Implications in the treatment of pneumococcal meningitis].
    Fernández Guerrero ML
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():40-3. PubMed ID: 9717160
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model.
    Klein M; Höhne C; Angele B; Högen T; Pfister HW; Tüfekci H; Koedel U
    Clin Microbiol Infect; 2019 Jan; 25(1):108.e9-108.e15. PubMed ID: 29649601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A.
    Ciccotelli W; Poutanen S; Morris S; Alqahtani M; Cox P; Low D; Pillai D; Opavsky M
    Can Commun Dis Rep; 2008 Nov; 34(11):1-6. PubMed ID: 19051388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant granulocyte colony-stimulating factor therapy results in improved spatial learning and stimulates hippocampal neurogenesis in a mouse model of pneumococcal meningitis.
    Schmidt AK; Reich A; Falkenburger B; Schulz JB; Brandenburg LO; Ribes S; Tauber SC
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):85-94. PubMed ID: 25470346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone.
    Barichello T; Goncalves JC; Generoso Jda S; Simoes LR; Tashiro MH; Goularte Jde A; Vuolo F; Rodrigues DH; Vilela MC; Petronilho F; Teixeira AL; Quevedo J
    Curr Neurovasc Res; 2014; 11(3):210-22. PubMed ID: 24845856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis.
    Brandt CT; Holm D; Liptrot M; Ostergaard C; Lundgren JD; Frimodt-Møller N; Skovsted IC; Rowland IJ
    J Infect Dis; 2008 Jan; 197(2):235-44. PubMed ID: 18173365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.
    Buckingham SC; McCullers JA; Luján-Zilbermann J; Knapp KM; Orman KL; English BK
    Pediatrics; 2006 May; 117(5):1688-94. PubMed ID: 16651325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia.
    Rijneveld AW; Florquin S; Hartung T; Speelman P; van der Poll T
    J Infect Dis; 2003 Jul; 188(2):282-5. PubMed ID: 12854084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
    Brandt CT; Lundgren JD; Frimodt-Møller N; Christensen T; Benfield T; Espersen F; Hougaard DM; Ostergaard C
    J Neuroimmunol; 2005 Sep; 166(1-2):126-31. PubMed ID: 15982752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clinically used antioxidants in experimental pneumococcal meningitis.
    Auer M; Pfister LA; Leppert D; Täuber MG; Leib SL
    J Infect Dis; 2000 Jul; 182(1):347-50. PubMed ID: 10882622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis.
    Hirst RA; Gosai B; Rutman A; Guerin CJ; Nicotera P; Andrew PW; O'Callaghan C
    J Infect Dis; 2008 Mar; 197(5):744-51. PubMed ID: 18260758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
    Muri L; Grandgirard D; Buri M; Perny M; Leib SL
    J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cochlear preservation after meningitis: an animal model confirmation of adjunctive steroid therapy.
    Addison J; Kim HH; Richter CP
    Laryngoscope; 2006 Feb; 116(2):279-82. PubMed ID: 16467719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal treatment with the anti-phosphorylcholine monoclonal antibody TEPC-15 decreases neuronal damage in experimental pneumococcal meningitis.
    Gerber J; Redlich S; Ribes S; Tauber SC; Schmidt H; Nau R
    Chemotherapy; 2012; 58(3):212-6. PubMed ID: 22759864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.